ARCH Venture Partners

The newly listed clinical-stage biotechnology company, Metsera Inc. (NASDAQ:MTSR) rose 15.01% on Monday as the broader markets declined. What Happened: While the company reported insider trades over the last month after its listing on Jan. 31, the stock has advanced 7.55% since it started trading...